SCHEMBL10186101

SCHEMBL10186101

CCCCOC(=O)c1c(F)cc(O[C@H]2CC[C@@H](C(=O)OCC)CC2)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.41
ALDH1A1 P00352 6/20 0.40
POLB P06746 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
KDM4E B2RXH2 2/20 0.38
HSP90AA1 P07900 1/20 0.37
TSHR P16473 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KCNH2 Q12809 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PDE4D Q08499 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10184970 1.00 ESR1 (0.41) ESR1ALDH1A1POLBTDP1KDM4E
SCHEMBL10184969 0.87 TSHR (0.42) ALDH1A1POLBTDP1KDM4ETSHR
SCHEMBL10148341 0.83 ALDH1A1 (0.44) ALDH1A1POLBTDP1KDM4ETSHR
SCHEMBL10148201 0.83 ALDH1A1 (0.44) ALDH1A1POLBTDP1KDM4ETSHR
SCHEMBL10148199 0.83 ALDH1A1 (0.44) ALDH1A1POLBTDP1KDM4ETSHR
SCHEMBL10148343 0.83 ALDH1A1 (0.44) ALDH1A1POLBTDP1KDM4ETSHR
SCHEMBL3040308 0.83 NR1H2 (0.44) ALDH1A1TDP1KDM4ERAB9ASMN1; SMN2
SCHEMBL10184844 0.79 CA12 (0.47) ESR1ALDH1A1POLBTDP1TSHR
SCHEMBL10184995 0.79 LMNA (0.46) ESR1ALDH1A1POLBTSHRNPC1
SCHEMBL10186099 0.78 TSHR (0.42) ALDH1A1POLBTDP1KDM4EHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046292-A1 DIACYLETHYLENEDIAMINE COMPOUND ASTELLAS PHARMA INC. (JP) 2012-02-23 US disclosed
WO-2010122968-A1 DIACYLETHYLENEDIAMINE COMPOUND アステラス製薬株式会社 (JP) 2010-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046292-A1 DIACYLETHYLENEDIAMINE COMPOUND DGAT1, DGAT2, DIMT1 ESR1 4281/4885ALDH1A1 963/4885POLB 3114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.